APEN NASDAQ
Apollo Endosurgery, Inc.
1W: +0.0%
1M: +0.9%
3M: +1.2%
1Y: +67.8%
3Y: +334.8%
5Y: +73.9%
$10.00
Last traded 2023-04-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$77M
+22.0% ▲
5Y CAGR: +3.6%
Gross Profit
$42M
+21.4% ▲
5Y CAGR: +1.3%
Operating Income
-$28M
-44.9% ▼
Net Income
-$40M
-61.4% ▼
EPS (Diluted)
$-0.98
-19.5% ▼
EBITDA
-$31M
-82.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $61M | $51M | $42M | $63M | $77M |
| YoY Growth | -5.4% | -16.7% | -17.1% | +49.8% | +22.0% |
| Cost of Revenue | $28M | $25M | $20M | $28M | $34M |
| Gross Profit | $33M | $26M | $22M | $35M | $42M |
| Gross Margin | 54.5% | 50.6% | 52.9% | 55.5% | 55.2% |
| R&D Expenses | $12M | $10M | $8M | $10M | $12M |
| SG&A Expenses | $46M | $42M | $28M | $43M | $57M |
| Operating Expenses | $66M | $55M | $38M | $54M | $70M |
| Operating Income | -$40M | -$29M | -$16M | -$19M | -$28M |
| Operating Margin | -65.9% | -57.4% | -37.6% | -30.5% | -36.2% |
| Interest Expense | $4M | $4M | $5M | $8M | $5M |
| Income Before Tax | -$46M | -$27M | -$22M | -$25M | -$39M |
| Tax Expense | $191K | $275K | $142K | $156K | $584K |
| Net Income | -$46M | -$27M | -$23M | -$25M | -$40M |
| Net Margin | -75.2% | -54.1% | -53.8% | -39.2% | -51.8% |
| EPS (Diluted) | $-2.31 | $-1.27 | $-0.99 | $-0.82 | $-0.98 |
| EBITDA | -$40M | -$26M | -$12M | -$14M | -$31M |
| Shares Outstanding | 20M | 22M | 23M | 30M | 41M |